{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T01:51:13Z","timestamp":1791165073889,"version":"4.1.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Drug Discov"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1038\/nrd2784","type":"journal-article","created":{"date-parts":[[2008,12,31]],"date-time":"2008-12-31T00:36:13Z","timestamp":1230683773000},"page":"17-18","source":"Crossref","is-referenced-by-count":50,"title":["Tetrabenazine"],"prefix":"10.1038","volume":"8","author":[{"given":"Michael R.","family":"Hayden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blair R.","family":"Leavitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uma","family":"Yasothan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kirkpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFnrd2784_CR1","volume-title":"Kelley's Textbook of Internal Medicine","author":"BR Leavitt","year":"2000","unstructured":"Leavitt, B. R. & Hayden, M. R. in Kelley's Textbook of Internal Medicine. 4th ed. (Lippincott, Williams and Wilkins, Philadelphia, 2000)."},{"key":"BFnrd2784_CR2","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/sj.embor.7400250","volume":"5","author":"C Landles","year":"2004","unstructured":"Landles, C. & Bates, G. P. Huntingtin and the molecular pathogenesis of Huntington's disease. EMBO Rep. 5, 958\u2013963 (2004).","journal-title":"EMBO Rep."},{"key":"BFnrd2784_CR3","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.cell.2006.04.026","volume":"125","author":"RK Graham","year":"2006","unstructured":"Graham, R. K. et al. Cleavage at the caspase 6 site in huntingtin is required for motor dysfunction, neurodegeneration and excitotoxicity in Huntington Disease. Cell 125, 1179\u20131191 (2006).","journal-title":"Cell"},{"key":"BFnrd2784_CR4","first-page":"51","volume":"4","author":"YA Grimbergen","year":"2003","unstructured":"Grimbergen, Y. A. & Roos, R. A. Therapeutic options for Huntington's disease. Curr. Opin. Invest. Drugs 4, 51\u201354 (2003).","journal-title":"Curr. Opin. Invest. Drugs"},{"key":"BFnrd2784_CR5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0022-3565(25)25665-8","volume":"127","author":"GP Quinn","year":"1959","unstructured":"Quinn, G. P., Shore, P. A. & Brodie, B. B. Biochemical and pharmacological studies of RO1-9569 (tetrabenazine), a non-indole tranquilizing agent with reserpine-like effects. J. Pharmacol. Exp. Ther. 127, 103\u2013109 (1959).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFnrd2784_CR6","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1136\/bmj.2.5654.422","volume":"2","author":"MA Dalby","year":"1969","unstructured":"Dalby, M. A. Effect of tetrabenazine on extrapyramidal movement disorders. BMJ 2, 422\u2013423 (1969).","journal-title":"BMJ"},{"key":"BFnrd2784_CR7","first-page":"227","volume":"37","author":"J Jankovic","year":"1983","unstructured":"Jankovic, J. Tetrabenazine in the treatment of hyperkinetic movement disorders. Adv. Neurol. 37, 227\u2013289 (1983).","journal-title":"Adv. Neurol."},{"key":"BFnrd2784_CR8","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/00002826-200211000-00003","volume":"25","author":"WG Ondo","year":"2002","unstructured":"Ondo, W. G. et al. Tetrabenazine treatment for Huntington's disease associated chorea. Clin. Neuropharmacol. 25, 300\u2013302 (2002).","journal-title":"Clin. Neuropharmacol."},{"key":"BFnrd2784_CR9","doi-asserted-by":"publisher","first-page":"E682","DOI":"10.1208\/aapsj080478","volume":"8","author":"G Zheng","year":"2006","unstructured":"Zheng, G., Dwoskin, L. P. & Crooks, P. A. Vesicular monoamine transporter 2: role as a novel target for drug development. AAPS J. 8, E682\u2013E692 (2006).","journal-title":"AAPS J."},{"key":"BFnrd2784_CR10","unstructured":"Food and Drug Administration. FDA labelling information. FDA web site [online] , (2008)."},{"key":"BFnrd2784_CR11","doi-asserted-by":"crossref","unstructured":"Huntington Study Group. Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial. Neurology 66, 366\u2013372 (2006).","DOI":"10.1212\/01.wnl.0000198586.85250.13"},{"key":"BFnrd2784_CR12","doi-asserted-by":"publisher","first-page":"A204","DOI":"10.1212\/01.WNL.0000113765.75855.19","volume":"62","author":"S Frank","year":"2004","unstructured":"Frank, S. et al. Functional decline due to chorea in Huntington's disease. Neurology 62, A204 (2004).","journal-title":"Neurology"},{"key":"BFnrd2784_CR13","unstructured":"National Institute of Neurological Disorders and Stroke (NINDS). Huntington's disease: hope through research. NINDS web site [online] , (2008)."},{"key":"BFnrd2784_CR14","unstructured":"IMS MIDAS (2007)."},{"key":"BFnrd2784_CR15","unstructured":"Gibbs, L. NewCrest Biovail Research Report (New Crest, 8 Oct 2008)."}],"container-title":["Nature Reviews Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrd2784.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrd2784","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrd2784.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T12:11:22Z","timestamp":1738843882000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrd2784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["BFnrd2784"],"URL":"https:\/\/doi.org\/10.1038\/nrd2784","relation":{},"ISSN":["1474-1776","1474-1784"],"issn-type":[{"value":"1474-1776","type":"print"},{"value":"1474-1784","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}